C-Corp, S-Corp or LLC: How Your Entity Type Affects Your Veterinary Practice Sale (2026)
C-Corp, S-Corp or LLC: How Your Entity Type Affects Your Veterinary Practice Sale (2026)
Key takeaways
- Your entity type decides how many times your sale gets taxed. A pass-through (S corp, LLC, partnership) is generally taxed once; a C corporation can be taxed twice on an asset sale, once at the 21 percent corporate level and again when the cash reaches you.
- The C-corp double-taxation gap is real money. On a multi-million-dollar practice, the difference between one layer of tax and two can run into seven figures of after-tax proceeds.
- Most practice sales are asset sales, and entity type changes how that lands. Pass-throughs handle the asset sale buyers want without an extra layer; C corps don’t, which is why the structure has to be planned, not assumed.
- The best fixes have built-in waiting periods. The built-in gains tax runs 5 years after a C-to-S election, and the qualified small business stock exclusion needs more than 5 years of holding, so these moves must start years before a sale.
- This is a planning conversation, not a closing-table fix. Entity choice should be reviewed with your CPA and tax attorney 3 to 5 years out, with your advisor coordinating it against the sale structure.
A vet I’d been talking with for a while called me one evening, a little rattled. He’d just gotten off the phone with his accountant after his first real offer came in.
The number on the offer was strong. The number his accountant said he’d actually keep was a lot smaller. “Nobody ever told me the letters after my practice name would cost me a million dollars,” he said.
The letters were “C corp.” And he wasn’t wrong.
That conversation is the reason this article exists. Selling a veterinary practice as a C corp vs an S corp, or as an LLC, or a partnership, is one of the largest swing factors in what you walk away with, and it’s the one almost nobody plans for. Most owners pick their entity type when they open the doors, for reasons that made sense at the time, and never revisit it.
Then a sale arrives and the choice they made a decade ago quietly decides how much of the price is theirs to keep.
Here’s the part that makes it urgent. The most valuable fixes can’t be done at the closing table.
They have waiting periods measured in years. So the time to understand this is now, while you still have runway, not the week a buyer hands you a letter of intent.
A quick, honest caveat before we go further. This is information, not tax advice.
Your situation is specific, the rules are detailed, and the right answer depends on facts only your CPA and tax attorney can confirm. What I can do is show you why the question matters and what to ask, so the planning starts early enough to help.
When we represent an owner, coordinating that planning with the deal structure is part of the work.
Your entity type is the legal form your practice operates under for tax purposes, sole proprietorship, partnership, LLC, S corporation, or C corporation. It determines how many layers of tax hit your sale and whether your gain is taxed as favorable capital gain or higher-rate ordinary income.
This sits alongside the broader tax picture we cover in our tax consequences of selling a veterinary practice guide, and it interacts directly with whether your deal is an asset sale or a stock sale. Here we go deep on the entity question specifically.
Why entity type is one of the biggest levers in your sale
Start with the one fact that drives everything else: almost every veterinary practice sells as an asset sale, a deal where the buyer purchases the practice’s assets, goodwill, equipment, records, and client relationships, rather than the ownership shares of the entity itself.
Buyers want asset sales for good reasons. They get a clean set of assets without inheriting the seller’s liabilities, and they get a step-up in basis, the tax cost the buyer carries in an asset, which they get to depreciate or amortize going forward.
The buyer’s preference for an asset sale is nearly universal, and it’s reasonable.
The problem is that an asset sale lands very differently depending on what entity you are. For a pass-through, it’s generally one layer of tax.
For a C corporation, it can be two. Same practice, same price, same offer, and a wildly different check at the end, purely because of the entity type.
That’s the lever. On a small sale the gap is annoying.
On a $3 million or $5 million practice, the difference between one layer of tax and two can be a seven-figure swing in after-tax money, the only money that actually matters once the deal is done. And unlike the multiple, which we fight to push up through a competitive process, the tax structure is something you mostly win or lose in advance through planning.
The two ways your sale can be taxed: pass-through vs C corporation
There are really only two tax worlds here, and almost everything about your sale flows from which one you’re in.
The first is the pass-through world. A pass-through entity is one that pays no federal income tax of its own; its income, and the gain on a sale, flow through to the owners’ personal returns and are taxed once.
S corporations, partnerships, and LLCs taxed as either are all pass-throughs.
In that world, an asset sale is generally taxed a single time, at your personal level. Per U.S.
Bank’s guidance for business owners, in a pass-through structure the seller generally won’t incur additional entity-level tax by characterizing the sale as one of assets rather than stock. The asset sale the buyer wants is workable for you, too.
The second world is the C corporation. A C corporation is a corporation taxed as its own separate entity; it pays corporate income tax on its profits, and shareholders pay tax again when those profits come out.
That second layer is the whole story when it’s time to sell.

The C corporation double-taxation problem
Let me walk the C-corp asset sale through, because this is where owners get genuinely surprised.
Double taxation is when the same sale proceeds get taxed twice: once at the corporate level, then again at the shareholder level. In a C-corp asset sale it works in two steps.
First, the corporation sells its assets and pays federal corporate income tax on the gain at a flat 21 percent rate, per PKF O’Connor Davies’ analysis of C-corporation sales. Then the corporation distributes the after-tax cash to you, the shareholder, and that distribution is taxed again on your personal return, generally as a dividend or capital gain up to 20 percent, plus the 3.8 percent net investment income tax where it applies.
Two bites out of the same apple. PKF O’Connor Davies frames it plainly: the seller is taxed first at the entity level at 21 percent, then again at the individual level when the proceeds are distributed.
The obvious response is, why not just sell the stock instead? A stock sale is a deal where the buyer purchases your ownership shares directly, so the gain is taxed once, to you, generally at capital-gains rates.
A stock sale sidesteps the corporate layer entirely.
The catch is the buyer. In a stock sale the buyer gets no basis step-up and inherits the entity’s history and liabilities, so buyers resist stock deals and often discount their offer to account for the lost depreciation.
So the C-corp owner is squeezed between a double-taxed asset sale and a discounted stock sale. That squeeze is exactly why C corporation veterinary practice sale tax planning has to happen early, while there’s still time to change the entity’s footing.
How S corp vs LLC and partnership sellers are taxed
Now the friendlier side of the ledger. If you’re a pass-through, the entity question is less about avoiding disaster and more about optimizing the split.
For an S corp vs LLC veterinary practice sale, the headline is similar: both are pass-throughs, so the asset sale is generally taxed once. Per Millan CPA’s 2026 pass-through guidance, LLCs taxed as partnerships, S corporations, and single-member LLCs all carry the gain through to the owners without a separate entity-level tax on a typical sale.
But “taxed once” doesn’t mean “taxed simply.” The single layer still gets split across asset classes, and the classes are taxed at different rates.
The IRS requires the sale to be allocated across the assets being sold, using what it calls the residual method, with each asset treated as sold separately. Per the IRS guidance on the sale of a business, capital assets and most intangibles produce capital gain, while inventory and depreciation recapture on equipment produce ordinary income.
Both sides report the agreed allocation, so it gets negotiated rather than assumed.
That’s why goodwill matters so much to your after-tax result, and why we wrote a separate deep-dive on veterinary practice goodwill. For a pass-through seller, the more of the price that lands in goodwill at capital-gains rates, the better your outcome, within the bounds of a defensible, fair-market allocation.
One nuance specific to the S corporation worth flagging: an S corporation is a corporation that elected pass-through treatment, so it generally pays no federal tax itself and the sale gain flows to the owners once. That’s clean, with one important exception, which is the next section, and it only applies to S corps that used to be C corps.
| Entity type | Layers of tax on an asset sale | Typical gain character | Key planning angle before a sale |
|---|---|---|---|
| Sole proprietorship / single-member LLC | One (personal level) | Mix of capital gain and ordinary income by asset class | Maximize defensible goodwill allocation |
| Partnership / LLC taxed as partnership | One (partners’ level) | Capital gain, with ordinary income on recapture and certain items | Allocation and partner-level basis review |
| S corporation | One (shareholder level) | Capital gain, with ordinary income on recapture | Watch built-in gains tax if recently converted from C corp |
| S corp via F-reorganization | One (shareholder level) | Capital gain to seller; buyer gets asset step-up | Set up well before closing; separate from the deal |
| C corporation | Up to two (corporate 21% + shareholder) | Corporate gain, then dividend/capital gain on distribution | Plan years ahead; consider conversion, QSBS, or stock structure |
This table is general information, not advice. The right path depends on facts only your CPA and tax attorney can confirm.
The C-to-S conversion, and the five-year trap most owners miss
So the natural question from every C-corp owner is, can’t I just convert to an S corp before I sell and make the double-tax problem go away? Sometimes.
But there’s a trap, and it’s a five-year one.
When a C corporation elects S status, the gain that was already baked into its assets at the moment of conversion doesn’t get a free pass. The built-in gains tax is a corporate-level tax under IRC Section 1374 on appreciation that existed at the time of a C-to-S conversion, if those assets are sold within a recognition period.
Per The Tax Adviser’s analysis of Section 1374, that built-in gains tax is imposed at the highest corporate rate, 21 percent, and the recognition period runs five years from the first day the S election takes effect. Sell appreciated assets inside that window, and the old C-corp gain can still get hit with a corporate-level tax, even though you’re now an S corp.
Wait out the full five years, and that exposure generally goes away. Per The Tax Adviser, dispositions after the recognition period expires are not subject to the built-in gains tax.
You can see why I keep hammering on timing. A C-to-S conversion done five-plus years before a sale can be powerful.
The same conversion done eighteen months before a sale may do very little for the assets that already appreciated. This is the single clearest example of why entity decisions belong years ahead of a closing, and why your CPA and tax attorney need to be in the room early.
The F-reorganization: the bridge between what buyers and sellers want
There’s an elegant tool that solves the buyer-wants-assets, seller-wants-stock standoff for S corporations, and it shows up in a large share of private-equity acquisitions for exactly that reason.
An F-reorganization is a pre-sale restructuring under IRC Section 368(a)(1)(F) where the owner forms a new holding company above the practice, so the deal can be a stock sale for the seller while still giving the buyer asset-sale treatment. Per CT Acquisitions’ 2026 guide to F-reorganizations, it’s used almost universally in private-equity acquisitions of S corporations.
The mechanics, in plain terms: you form a new holding company, contribute your operating-entity stock to it tax-free, and elect to treat the operating entity as disregarded. The buyer then acquires the operating-entity interests, which the IRS treats as an asset purchase, while you’re treated as selling stock.
The payoff is that both sides get what they need. Per CT Acquisitions, the buyer gets asset-sale treatment with a full step-up in basis on depreciable assets, while the seller reports a stock sale generally at favorable capital-gains rates.
The conflict dissolves.

There’s a timing rule here too, which by now should sound familiar. Per CT Acquisitions, the restructuring needs proper setup time, often a month or two, and is typically separated from the sale itself by a meaningful interval so it isn’t collapsed into a single step.
You can’t bolt it on the day before closing. Like everything else in this article, it rewards the owner who started planning early.
A close cousin worth knowing by name is the Section 338(h)(10) election, another mechanism that lets a transaction structured as a stock sale be treated as an asset sale for tax purposes. Per PKF O’Connor Davies, both the 338(h)(10) election and F-reorganizations exist to give buyers the asset step-up they want inside a stock-form deal.
Which one fits depends on your entity and facts, and that’s squarely a CPA-and-attorney call.
The 2026 numbers that make this concrete
Abstract percentages don’t land until you see the rates side by side. Here’s the 2026 federal picture for the rates that drive this whole decision.
Long-term capital gains in 2026 are taxed at 0, 15, or 20 percent. Per the Tax Foundation’s 2026 brackets, a single filer hits the 20 percent rate above $545,500 of taxable income, and married couples filing jointly hit it above $613,700.
Most practice sellers land in the 20 percent bracket on the bulk of their gain, and the 3.8 percent net investment income tax often applies on top.
Ordinary income, by contrast, tops out at 37 percent. Per the Tax Foundation, the 37 percent rate hits above $640,600 for single filers and $768,600 for married couples filing jointly.
That’s the rate that applies to depreciation recapture and other ordinary-income pieces of your deal.
Now stack the C-corp math on top. A C-corp asset sale runs the corporate 21 percent first, and then the distribution is taxed again at up to 20 percent plus the 3.8 percent net investment income tax.
Run two layers like that against a single capital-gains layer on the same proceeds, and on a large practice the spread is easily into seven figures. That gap is the prize that early entity planning is fighting for.
We model exactly this kind of after-tax comparison as part of valuing a veterinary practice and preparing it for market.
One more 2026 angle, going the other direction. For owners who’ll genuinely hold a C corporation for the long haul before any exit, qualified small business stock under Section 1202 can exclude a large share of the gain on C-corp shares held more than five years, per MGO’s analysis of QSBS planning.
It’s not a fit for most selling vets, the five-year-plus holding requirement alone rules out near-term sellers, but it’s a reminder that the C corporation isn’t always the villain. The point isn’t that one entity is best.
The point is that the right entity depends on your timeline, and the clock starts years before the sale.
Why this has to be reviewed years before the sale, not at closing
If there’s one idea I want to leave you with, it’s that the entity decision is a planning decision, and planning needs runway.
Look at the pattern across everything above. The built-in gains tax recognition period is five years.
The qualified small business stock exclusion needs more than five years of holding. The F-reorganization needs setup time and separation from the deal.
None of these are levers you can pull at the closing table.
That’s the difference between the entity question and most of the rest of the sale. We can run a competitive process and push your multiple in a matter of months.
We cannot retroactively give you a five-year head start on a conversion you didn’t make. The entity work either got done in advance, or the window closed.
So the practical move is simple. Three to five years before you think you might sell, sit down with your CPA, your tax attorney, and an advisor who’s seen how these structures play out in real deals, and pressure-test your entity type against your exit plan.
Most owners I talk with have never had that conversation. The ones who have it early are the ones who keep the most.
How entity type and deal structure get planned together
Here’s where the two halves connect, because entity type and deal structure aren’t separate decisions. They’re one decision.
Your entity determines which structures are even available to you without a tax penalty, and the structure determines how your entity gets taxed. A pass-through can comfortably do the asset sale a buyer wants.
A C corp may need a stock structure, or a conversion well in advance, or a negotiated tax adjustment to make an asset sale tolerable. An S corp may want an F-reorganization to give the buyer what they need while protecting the seller’s rate.
The way we move the headline number is the Elite Selling System. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group.
That process drives the multiple. But a higher multiple taxed badly can still lose to a lower multiple taxed well, which is why we coordinate the structure and the entity planning with your CPA and attorney from the start, not after the offer arrives.
That coordination is the quiet difference between a strong headline and a strong check. We see it in our work constantly: across the deals we’ve closed over the past four-plus years, the owners who planned their entity and structure early consistently kept more of an equivalent price than the ones who left it to the closing table.
What this means for your practice
Pull it all together and the through-line is clear. Your entity type sets the tax baseline for your entire sale, the asset-versus-stock structure interacts with it, and the most valuable adjustments take years to mature.
If you’re a pass-through, your job is mostly optimization: a defensible allocation that puts as much of the price as possible into capital-gains treatment. If you’re a C corporation, your job is bigger, and earlier: understand the double-taxation exposure, and work with your advisors on whether a conversion, a stock structure, or another path fits your timeline.
Either way, the worst outcome is finding out at the closing table.
This is also why the entity review belongs inside a broader preparation plan rather than as a standalone tax errand. We walk through that full runway in our guide to selling a veterinary practice and our work on preparing your veterinary practice for sale, where entity and structure planning sits right alongside the operational and financial work.
What to do next
If you take one thing from all of this, take this: the letters after your practice name are worth real money, and the time to look at them is while you still have years on the clock.
The most useful first step is simply understanding what your practice is worth and how your current entity would be taxed on a sale, so you can see the gap between your headline value and your after-tax proceeds. That picture tells you whether there’s planning worth doing, and how much runway you’d need to do it.
Get a Free Practice Value Estimate →
We pull your numbers, build a defensible normalized EBITDA, and show you what your practice would likely clear, then coordinate with your CPA and tax attorney so the entity and structure are working for you rather than against you. The estimate is free and there’s no obligation to engage further.
The Transitions Elite engagement model is success-based, with no upfront fees and no retainer, so we only get paid when a deal closes and only out of the value our process delivers.
Further reading
These are the TE resources I’d point any vet toward as they think about structure, tax, and a future sale. Each goes deep on one piece of the picture.
- Tax consequences of selling a veterinary practice — the full tax picture your entity type sits inside.
- Veterinary practice asset sale vs stock sale — the deal-structure decision that interacts with entity type.
- Veterinary practice goodwill — why goodwill allocation drives your after-tax result.
- How to value a veterinary practice — what your practice is actually worth before tax.
- Guide to selling a veterinary practice — the full owner’s runway to a sale.
- Preparing your veterinary practice for sale — where entity and structure planning fits in the prep work.
Frequently asked questions
What is the difference between selling a veterinary practice as a C corp vs an S corp?
A C corporation can be taxed twice on a sale of its assets: once at the 21 percent corporate level, then again on the shareholder’s personal return when the cash is distributed. An S corporation is a pass-through, so the gain is generally taxed once, at the owner’s personal rate.
Because most veterinary practice sales are structured as asset sales, the entity type can change your after-tax proceeds by a large margin, which is why C-corp owners benefit most from planning the structure years before a sale.
How does a C corporation get double-taxed when selling a veterinary practice?
In an asset sale, the C corporation first pays the 21 percent federal corporate tax on its gain. Then, when the remaining cash is distributed to the owner, it is taxed again at the shareholder level, generally as a dividend or capital gain up to 20 percent plus the 3.8 percent net investment income tax.
The same dollars are taxed twice. A stock sale avoids the corporate layer but buyers usually prefer to buy assets, so this trade-off has to be negotiated and planned in advance.
Why does entity type matter so much when selling a veterinary practice?
Entity type decides how many layers of tax apply to your sale proceeds and whether your gain is taxed as favorable capital gain or higher-rate ordinary income. A pass-through such as an S corp, LLC, or partnership is generally taxed once.
A C corporation can be taxed twice on an asset sale. On a multi-million-dollar practice that difference can run into seven figures of after-tax money, and the fixes mostly have to be in place years before you go to market.
How are LLC and partnership veterinary practices taxed on a sale?
An LLC taxed as a partnership or a sole proprietorship is a pass-through, so an asset sale is generally taxed once, at the owners’ personal level, with no separate entity-level tax. That makes the asset sale that most buyers want relatively painless on the seller’s side.
The catch is that the gain is split across asset classes: goodwill and most intangibles get capital-gains treatment, while depreciation recapture on equipment is taxed as ordinary income. An LLC can also elect to be taxed as an S corp or C corp, which changes the analysis entirely.
What is an F-reorganization and how does it help sell a veterinary practice?
An F-reorganization is a pre-sale restructuring under IRC Section 368(a)(1)(F) where an S-corporation owner forms a new holding company above the practice. The buyer can then acquire the practice as an asset purchase with a step-up in basis, while the seller is treated as selling stock and keeps capital-gains rates.
It resolves the classic buyer-wants-assets, seller-wants-stock conflict. It needs proper setup time and is usually separated from the closing by a meaningful interval, so it has to be planned with a CPA and tax attorney well before the deal.
Should I convert my veterinary practice from a C corp to an S corp before selling?
It can help, but timing is everything. When a C corporation elects S status, a built-in gains tax under IRC Section 1374 applies to appreciation that existed at conversion if the assets are sold within a five-year recognition period, at the 21 percent corporate rate.
Sell inside that window and you can still face a corporate-level tax on the old gain. Wait out the full five years and that exposure generally disappears.
That is exactly why entity decisions belong years ahead of a sale, not at closing, and why they need a CPA and tax attorney.
When should I review my veterinary practice entity type before a sale?
Ideally three to five years before you intend to sell. The most powerful entity moves have built-in waiting periods: the built-in gains tax recognition period after a C-to-S election runs five years, and the qualified small business stock exclusion requires holding C-corp shares for more than five years.
An F-reorganization needs setup time and separation from the closing. None of these can be done the week before a letter of intent, so the entity review is one of the first conversations to have with your CPA, tax attorney, and advisor.
Does entity type affect whether my veterinary practice sells as an asset sale or a stock sale?
Yes. For pass-through entities such as S corps, LLCs, and partnerships, an asset sale is generally taxed once, so the asset structure most buyers prefer is workable for sellers.
For a C corporation, an asset sale triggers double taxation, so the seller may push for a stock sale, which buyers resist because they lose the basis step-up. Tools like the F-reorganization and the Section 338(h)(10) election exist to bridge that gap, but the right path depends on your entity, which is why structure and entity type have to be planned together.
Sources
Federal tax rates and IRS rules
- Internal Revenue Service. “Sale of a Business.” irs.gov
- Tax Foundation. “2026 Tax Brackets and Federal Income Tax Rates.” taxfoundation.org
- Kiplinger. “IRS Updates Capital Gains Tax Thresholds for 2026.” kiplinger.com
- The Tax Adviser. “The Built-In Gains Tax.” thetaxadviser.com
Entity structure and sale tax treatment
- PKF O’Connor Davies. “Sale of a C Corporation — Buy and Sell Tax Implications for Stock & Asset Sales.” pkfod.com
- U.S. Bank. “Tax Implications of Selling a Business.” usbank.com
- Millan & Co. CPA. “2026 Business & Pass-Through Tax Rules: QBI, SALT & Section 179 Updates.” millancpa.com
- CT Acquisitions. “F-Reorganization Business Sale Tax Treatment (2026 Guide).” ctacquisitions.com
- MGO. “QSBS: Converting an LLC or S Corp Before a Sale.” mgocpa.com

Melani Seymour, co-founder of Transitions Elite, helps veterinary practice owners take action now to maximize value and secure their future.
With over 15 years of experience guiding thousands of owners, she knows exactly what it takes to achieve the best outcome.
Ready to see what your practice is worth?